The folic acid combined with 17-β estradiol produces antidepressant-like actions in ovariectomized rats forced to swim

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 1, 2011, Pages 60-66

  Molina Hernández, Miguel ^a   Téllez Alcántara, N Patricia ^a   Olivera López, Jorge I ^b,c   Jaramillo, M Teresa ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Antidepressant; Estradiol; Folic acid; Forced swimming test

Indexed keywords

ANTIDEPRESSANT AGENT; ESTRADIOL; FLUOXETINE; FOLIC ACID; KETANSERIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG MECHANISM; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; NONHUMAN; OPEN FIELD TEST; OVARIECTOMY; RAT; SEROTONINERGIC SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ESTRADIOL; EXPLORATORY BEHAVIOR; FEMALE; FLUOXETINE; FOLIC ACID; INJECTIONS, INTRAVENTRICULAR; OVARIECTOMY; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 78650952245     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.022     Document Type: Article

References (53)

1. Abou-Saleh M., Coppen A. Folic acid and the treatment of depression. J Psychosomatic Res 2006, 61:285-287.
2. Alpert J., Mischoulon D., Rubenstein G., Bottonari K., Nierenberg A., Fava M. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002, 14:33-38.
3. Bjelland I., Tell G., Vollset S., Refsum H., Ueland P. Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 2003, 60:618-626.
4. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988, 94:147-160.
5. Brocardo P., Budni J., Kaster M., Santos A., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473a.
6. Brocardo P., Budni J., Ribas K., Pinto M., Rodrigues A.L. Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur J Pharmacol 2008, 598:37-42b.
7. Brotto L., Barr A., Gorzalka B. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol 2000, 402:87-93.
8. Brustolin S., Giugliani R., Félix T.M. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res 2010, 43:1-7.
9. Cervo L., Grignaschi G., Samanin R. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin-1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 1988, 158:53-59.
10. Cho Y.J., Han J.Y., Choi J.S., Ahn H.K., Ryu H.M., Kim M.Y., et al. Prenatal multivitamins containing folic acid do not decrease prevalence of depression among pregnant women. J Obstet Gyneacology 2008, 28:482-484.
11. Coppen A., Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled study. J Affective Disorders 2000, 60:121-130.
12. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav 1985, 9:37-44.
13. D'Anci K.E., Rosenberg I.H. Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care 2004, 7:659-664.
14. De Cree C., Malinow M.R., van Kranenburg G.P., Geurten P.G., Longford N.T., Keizer H.A. Influence of exercise and menstrual cycle phase on plasma homocysteine levels in young women-a prospective study. Scand J Med Sci Sports 1999, 272-278.
15. Delini-Stula A., Mikkelsen H., Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression - a metaanalysis of moclobemide studies. J Affect Disord 1995, 35:21-30.
16. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 1996, 73:43-46.
17. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
18. Dodd S., Horgan D., Malhi G., Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affectiv Disord 2005, 89:1-11.
19. Estrada E., Fernández-Guasti A., López C. Participation of the 5HT-1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacol 2006, 31:247-255.
20. Estrada-Camarena E., Fernández-Guasti A., López-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 2003, 28:830-838.
21. Estrada-Camarena E., Fernández-Guasti A., López-Rubalcava C. Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology 2004, 173:139-145.
22. Fava M. Augmenting antidepressants with folate: a clinical perspective. J Clin Psychiatry 2007, 10:4-7.
23. Gavioli E.C., Duarte F., Bressan E., Ferrara P., Coimbra R., Monteiro De Lima T.C. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test. Eur J Pharmacol 2003, 471:21-26.
24. Gilbody S., Lightfoot T., Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007, 61:631-637.
25. Gutiérrez A., Contreras C.M., Mendoza R., García O., Cruz J.S. Urine from stressed rats increases immobility in receptor rats forced to swim: role of 2-heptanone. Physiol Behav 2007, 91:166-172.
26. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond A., et al. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 1999, 364:123-132.
27. Harma M., Harma M., Kocyigit A., Yaltali T. Intranasal 17β betha-estradiol treatment and vitamin B12, folate and homo cysteine in menopause. Maturitas 2005, 50:353-358.
28. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neuroscience Biobehav Rev 2001, 25:117-142.
29. Krumdieck C.L., Boots L.R., Cornwell P.E., Bulterworth C.E. Cyclic variations in folate composition and pteroylpolyglutamyl hydrolase (conjugase) activity of the rat uterus. Am J Clin Nutr 1976, 29:288-294.
30. López-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
31. Martins P.J., Camargo L., Goncalves F., Levy M., Benedito A., Tufika S., et al. Physiological variation in plasma total homocysteine concentrations in rats. Life Sci 2005, 76:2621-2629.
32. Merki-Feld G.S., Imthurn B., Keller P.J. The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels. Horm Metab Res 2000, 32:288-293.
33. Miller K.J., Conney J.C., Rasgon N.L., Fairbanks L.A., Small G.W. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 2002, 50:1826-1830.
34. Molina-Hernández M., Téllez-Alcántara N.P., Olivera-Lopez J.I., Jaramillo T. Olanzapine plus 17-β estradiol produce antidepressant-like actions in rats forced to swim. Pharmacol Biochem Behav 2009, 93:491-497.
35. National Institutes of Health Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
36. Papakostas G., Petersen T., Lebowitz B., Mischoulon D., Ryan J., Nierenberg A., et al. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005, 8:1-6.
37. Paul R., McDonnell A., Kelly C. Folic acid: neurochemistry, metabolism and relationship to depression. Human Psychopharmacol: Clin Exp 2004, 19:477-488.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1982, Academic Press, New York.
39. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
40. Resler G., Lavie R., Campos J., Mata S., Urbina M., García M., et al. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homcysteine and vitamin B12 and serotonin levels in lymphocytes. Neuroimmunomodulation 2008, 15:145-152.
41. Reynolds E.H., Preece J.M., Path M.C., Bailey J., Coppen A. Folate deficiency in depressive illness. Brit J Psychiatry 1970, 117:287-292.
42. Sahar E., Sousou A., Mervat A., Hoda M. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy. J Pharmacy Pharmacol 2002, 54:391-397.
43. Setnik B., Goncalves F., d'Almeida V., Nobrega J. Increased homocysteine levels associated with sex and stress in the learned helplessness model of depression. Pharmacol Biochem Behav 2004, 77:155-161.
44. Sloan D., Kornstein S. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003, 26:581-594.
45. Smolders R., Meer K., Kenemans P., Jakobs C., Kulik W., van der Mooren M. Oral estradiol decreases plasma homocysteine, vitamin B6, and albumin in postmenopausal women but does not change the whole-body homocysteine remethylation and transmethylation flux. J Clin Endocrinology Metabolism 2005, 90:2218-2224.
46. Stahl S. Novel therapeutics for depression: l-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 2007, 12:739-744.
47. Taylor M., Carney S., Goodwin G., Geddes J. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004, 18:251-256.
48. Toprak A., Erenus M., Ilhan A., Haklar G., Fak A., Oktay A. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Climacteric 2005, 8:279-286.
49. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988, 31:959-962.
50. Urbina M., Lavie R., Resler G., Campos J., Mata S., Lima L. Síntesis de serotonina y presencia de hidroxilasa de triptófano en linfocitos de pacientes con depresión mayor tratados con fluoxetina y ácido fólico. Archiv Venezolanos Farmacol Ter 2008, 27:114-120.
51. Walf A., Frye C.A. Parity and estrogen-administration alter affective behavior of ovariectomized rats. Physiol Behav 2008, 93:351-356.
52. Westlund L., Parry B. Does estrogen enhance the antidepressant effects of fluoxetine?. J Affective Disorders 2003, 77:87-92.
53. Zmuda J.M., Bausserman L.L., Maceroni D., Thompson P.D. The effect of supraphysiologic doses of testosterone on fasting total homocysteine levels in normal men. Atherosclerosis 1997, 130:199-202.